from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0839/-

LFCtreatmentdescriptionclass of inhibitor

-0.417

Amikacinug/mL Amikacintranslation

-0.841

Cap5-10ug/mL Capreomycintranslation

-0.472

Rox10-50 ug/mL Roxithromycintranslation

-0.453

SM2-5 ug/mL Streptomycintranslation

-0.828

Tet5-10 ug/mL Tetracyclinetranslation

0.151

Rif0.2-5ug/mL Rifampicintranscription

-0.169

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.033

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.463

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.454

CPZ10-50 ug/mL Chlorpromazinerespiration

0.952

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.141

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.387

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.363

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.743

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.350

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.820

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.135

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.927

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.193

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.690

KCN5-20 ug/mL Potassium cyaniderespiration

-0.538

NaN30.2-2 mM Sodium aziderespiration

0.331

Nigericin50 uM Nigericinrespiration

-0.361

TRC10-150 ug/mL Triclosanrespiration

-0.042

TRZ10-25 ug/mL Thioridazinerespiration

2.590

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.512

menadione6-10 ug/mL Menadionerespiration

0.205

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.263

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.546

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.073

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.014

NRP_1Non-replicating persistence stage 1dosRassociated

-0.202

Amp0.2mg/mL AmpicillincellWall

-0.210

Cephalexin20-100 ug/mL CephalexincellWall

-0.508

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.443

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.103

EMB10-20 ug/mL EthambutolcellWall

-0.295

Eta12-40 ug/mL EthionamidecellWall

-0.266

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.295

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.045

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.049

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.716

BZA0.12 mg/mL BenzamidearomaticAmides

-0.313

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.062

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.537

H2O24 mM hydrogen peroxideDNAdamaging

0.004

Levo10 ug/mL LevofloxacinDNAdamaging

-0.456

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.200

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.029

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.422

UVUV-irradiationDNAdamaging

3.650

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.208

Antimycin12.5-50 ug/mL Antimycin A?

0.273

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.962

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.687

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.306

PA8240.2-2 ug/mL PA-824?

0.321

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.068

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.422

Verapamil50 uM Verapamil?

-0.131

mercaptoethanol2 mM 2-Mercaptoethanol?

0.065

methoxatin10-20 ug/mL Methoxatin?